Lv1
58 积分 2022-03-21 加入
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial
23天前
已完结
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
3个月前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients
3个月前
已完结
Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement
5个月前
已完结
Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial
6个月前
已完结
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
7个月前
已完结
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
8个月前
已完结
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
8个月前
已完结
High risk of activation of latent tuberculosis infection in rheumatic disease patients
8个月前
已完结
综合医疗机构结核病发病高危人群的预防性治疗专家共识
8个月前
已完结
皖公网安备34019202002308
